Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118309) titled 'Clinical Study of Targeted Programmed Death Ligand-1 (PD-L1) Molecular Probe' on Feb. 4.
Study Type: Interventional study
Study Design:
Non randomized control
Primary Sponsor: The First Affiliated Hospital of Guilin Medical University
Condition:
Malignant tumor
Intervention:
Group A: 18F-PDL1P and 18F-FDG PET imaging group:Injection of 18F-PDL1P imaging agent
Recruitment Status: Not Recruiting
Phase: 0
Date of First Enrollment: 2026-03-02
Target Sample Size: Group A: 18F-PDL1P and 18F-FDG PET imaging group:10;Group B: 68Ga-PDL1P and 18F-FDG PET imaging group:10;
Countries of Recruitment:
China
To...